94 related articles for article (PubMed ID: 22386994)
1. T cells stimulate catabolic gene expression by the stromal cells from giant cell tumor of bone.
Cowan RW; Ghert M; Singh G
Biochem Biophys Res Commun; 2012 Mar; 419(4):719-23. PubMed ID: 22386994
[TBL] [Abstract][Full Text] [Related]
2. PTHrP increases RANKL expression by stromal cells from giant cell tumor of bone.
Cowan RW; Singh G; Ghert M
J Orthop Res; 2012 Jun; 30(6):877-84. PubMed ID: 22102368
[TBL] [Abstract][Full Text] [Related]
3. Evidence for the role of matrix metalloproteinase-13 in bone resorption by giant cell tumor of bone.
Mak IW; Seidlitz EP; Cowan RW; Turcotte RE; Popovic S; Wu WC; Singh G; Ghert M
Hum Pathol; 2010 Sep; 41(9):1320-9. PubMed ID: 20573369
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of MMP-13 via Runx2 in the stromal cell of Giant Cell Tumor of bone.
Mak IW; Cowan RW; Popovic S; Colterjohn N; Singh G; Ghert M
Bone; 2009 Aug; 45(2):377-86. PubMed ID: 19422937
[TBL] [Abstract][Full Text] [Related]
5. CCAAT/enhancer binding protein beta is up-regulated in giant cell tumor of bone and regulates RANKL expression.
Ng PK; Tsui SK; Lau CP; Wong CH; Wong WH; Huang L; Kumta SM
J Cell Biochem; 2010 May; 110(2):438-46. PubMed ID: 20225273
[TBL] [Abstract][Full Text] [Related]
6. Parathyroid hormone-related protein (PTHrP) modulates adhesion, migration and invasion in bone tumor cells.
Mak IW; Turcotte RE; Ghert M
Bone; 2013 Jul; 55(1):198-207. PubMed ID: 23466453
[TBL] [Abstract][Full Text] [Related]
7. Ultrastructural and cytobiological studies on possible interactions between PTHrP-secreting tumor cells, stromal cells, and bone cells.
Ito M; Amizuka N; Tanaka S; Funatsu-Ozawa Y; Kenmotsu S; Oda K; Nakajima T; Ozawa H
J Bone Miner Metab; 2003; 21(6):353-62. PubMed ID: 14586791
[TBL] [Abstract][Full Text] [Related]
8. Transcriptomic and proteomic analyses in bone tumor cells: Deciphering parathyroid hormone-related protein regulation of the cell cycle and apoptosis.
Mak IW; Turcotte RE; Ghert M
J Bone Miner Res; 2012 Sep; 27(9):1976-91. PubMed ID: 22508574
[TBL] [Abstract][Full Text] [Related]
9. MiR-126-5p regulates osteoclast differentiation and bone resorption in giant cell tumor through inhibition of MMP-13.
Wu Z; Yin H; Liu T; Yan W; Li Z; Chen J; Chen H; Wang T; Jiang Z; Zhou W; Xiao J
Biochem Biophys Res Commun; 2014 Jan; 443(3):944-9. PubMed ID: 24360951
[TBL] [Abstract][Full Text] [Related]
10. Effect of cytokines on in vitro bone resorption by cells isolated from giant cell tumor of bone.
Wen J; Xie D; Yao J; Zhang M; Bi J
Chin Med J (Engl); 1999 May; 112(5):443-7. PubMed ID: 11593516
[TBL] [Abstract][Full Text] [Related]
11. Expression of osteoclast differentiation signals by stromal elements of giant cell tumors.
Atkins GJ; Haynes DR; Graves SE; Evdokiou A; Hay S; Bouralexis S; Findlay DM
J Bone Miner Res; 2000 Apr; 15(4):640-9. PubMed ID: 10780856
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the anti-tumor effects of denosumab and zoledronic acid on the neoplastic stromal cells of giant cell tumor of bone.
Lau CP; Huang L; Wong KC; Kumta SM
Connect Tissue Res; 2013; 54(6):439-49. PubMed ID: 24060052
[TBL] [Abstract][Full Text] [Related]
13. PTHrP regulates angiogenesis and bone resorption via VEGF expression.
Isowa S; Shimo T; Ibaragi S; Kurio N; Okui T; Matsubara K; Hassan NM; Kishimoto K; Sasaki A
Anticancer Res; 2010 Jul; 30(7):2755-67. PubMed ID: 20683010
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic and molecular studies of giant-cell tumors of bone and soft tissue.
Lau YS; Sabokbar A; Gibbons CL; Giele H; Athanasou N
Hum Pathol; 2005 Sep; 36(9):945-54. PubMed ID: 16153456
[TBL] [Abstract][Full Text] [Related]
15. Parathyroid hormone-related peptide (PTHrP), parathyroid hormone/parathyroid hormone-related peptide receptor 1 (PTHR1), and MSX1 protein are expressed in central and peripheral giant cell granulomas of the jaws.
Houpis CH; Tosios KI; Papavasileiou D; Christopoulos PG; Koutlas IG; Sklavounou A; Alexandridis C
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Mar; 109(3):415-24. PubMed ID: 20060342
[TBL] [Abstract][Full Text] [Related]
16. Expression of RANK-ligand in prostate cancer cell lines.
Penno H; Nilsson O; Brändström H; Winqvist O; Ljunggren O
Scand J Clin Lab Invest; 2009; 69(1):151-5. PubMed ID: 19058084
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase 9 (gelatinase B) is expressed in multinucleated giant cells of human giant cell tumor of bone and is associated with vascular invasion.
Ueda Y; Imai K; Tsuchiya H; Fujimoto N; Nakanishi I; Katsuda S; Seiki M; Okada Y
Am J Pathol; 1996 Feb; 148(2):611-22. PubMed ID: 8579123
[TBL] [Abstract][Full Text] [Related]
18. RANK ligand is a prerequisite for cancer-associated osteolytic lesions.
Kitazawa S; Kitazawa R
J Pathol; 2002 Oct; 198(2):228-36. PubMed ID: 12237883
[TBL] [Abstract][Full Text] [Related]
19. Importance of membrane- or matrix-associated forms of M-CSF and RANKL/ODF in osteoclastogenesis supported by SaOS-4/3 cells expressing recombinant PTH/PTHrP receptors.
Itoh K; Udagawa N; Matsuzaki K; Takami M; Amano H; Shinki T; Ueno Y; Takahashi N; Suda T
J Bone Miner Res; 2000 Sep; 15(9):1766-75. PubMed ID: 10976996
[TBL] [Abstract][Full Text] [Related]
20. Receptor activator of NF-kappaB ligand enhances breast cancer-induced osteolytic lesions through upregulation of extracellular matrix metalloproteinase inducer/CD147.
Rucci N; Millimaggi D; Mari M; Del Fattore A; Bologna M; Teti A; Angelucci A; Dolo V
Cancer Res; 2010 Aug; 70(15):6150-60. PubMed ID: 20631064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
